Chronic kidney disease

Chronic kidney disease (CKD) is defined as an abnormality of the kidney structure or function for ≥ 3 months. The most common causes of CKD in the United States are diabetes mellitus, hypertension, and glomerulonephritis. Since the kidneys have exceptional compensatory mechanisms, most patients remain asymptomatic and are unaware of their condition until their kidney function is significantly impaired. Patients typically present with symptoms of fluid overload (e.g., peripheral edema) and uremia. Laboratory evaluation shows hyperkalemia, hyperphosphatemia, and hypocalcemia, as well as metabolic acidosis. Management focuses mainly on treating the underlying disease and preventing possible complications, e.g., treating hypertension, avoiding nephrotoxic substances, and maintaining adequate hydration. If chronic kidney disease progresses to end-stage renal disease (ESRD), renal replacement therapy (dialysis) or a kidney transplant is necessary.

• Chronic kidney disease is defined as an abnormality of the kidney structure or function for ≥ 3 months.

Associated with an irreversible reduction of the excretory (glomerular, tubular) and the endocrine functions of the kidney

References:^[1]

• About 10% of adults in the US suffer from chronic kidney disease.
• African Americans are at increased risk of developing chronic kidney disease.

References:^[2][3]

Epidemiological data refers to the US, unless otherwise specified.

References:^[3][4][5]

• Patients are often asymptomatic until later stages.
• Hypertension
• Peripheral edema
• Pulmonary edema (usually interstitial pulmonary edema)
• Clinical features of uremia
  • Fatigue, weakness, loss of appetite, headaches
    • Uremic fetor
  • Pigmented spots
  • Pruritus
  • Anemia
  • Uremic pericarditis
    • Friction rub on auscultation
    • Diagnostics: Uremic pericarditis does not show typical ECG changes such as diffuse ST-segment elevation.
  • Pleuritis
  • Asterixis
  • Encephalopathy; : seizures, somnolence, coma
  • Peripheral neuropathy: paresthesias
  • Gastrointestinal symptoms: nausea, vomiting
  • ↑ Risk of infection: leukocyte dysfunction
  • ↑ Bleeding tendency secondary to platelet dysfunction
• Chronic kidney disease-mineral and bone disorder (CKD-MBD): abnormalities of mineral or bone metabolism in the setting of chronic renal disease
  • Etiology: mostly due to secondary hyperparathyroidism; → high-turnover renal osteodystrophy or osteitis fibrosa cystica
  • Clinical features: : weakness, fractures, bone pain, avascular necrosis

Patients develop secondary hyperparathyroidism and subsequent renal osteodystrophy due to hyperphosphatemia, hypocalcemia, and the insufficient production of vitamin D!

References:^{[6][7][8][9][10][11][12][13]}

• Blood
  • ↑ Creatinine and BUN
  • Electrolytes: hyperkalemia, hyperphosphatemia, hypocalcemia
  • Monitor blood pH for metabolic acidosis
  • ↓ Calcitriol levels
  • ↑ Parathyroid hormone (PTH)
  • Coagulation testing: ↔︎ PT, PTT, platelet count, ↑ bleeding time caused by uremic coagulopathy
  • Anemia of chronic kidney disease: ↓ hemoglobin, ↔︎ MCV
    • Pathophysiology: ↓ erythropoietin → decreased stimulation of RBC production → normocytic, normochromic anemia
• Urinalysis: : possibly abnormal urine sediment (see nephritic sediment, nephrotic sediment)
• Ultrasound: shrunken kidneys and fibrotic parenchyma
• Renal biopsy: sometimes indicated to determine the underlying cause

In chronic renal disease, close surveillance of serum potassium values as well as calcium and phosphate values is essential!References:^{[13][14][15][16]}

• Diet
  • Salt restriction in patients with edema or hypertension
  • See treatment of hyperkalemia.
  • See treatment of acid-base disorders.
• Nephrotoxic substances avoidance
  • NSAIDs
  • Nicotine
  • Sulfonamide antibiotics, aminoglycosides, vancomycin
  • Acyclovir
  • Cisplatin
  • Others (e.g., lead, amphetamines, amphotericin B, radiographic contrast material)
• Strict blood pressure control
  • Well-controlled blood pressure is essential to prevent disease progression.
  • See treatment of hypertension.
• Vaccinations
  • All patients with CKD
    • Pneumococcal vaccine every 5 years
    • Influenza vaccine annually
  • Susceptible patients: hepatitis B vaccine (see high-risk groups for HBV infection)

• Special patient groups
  • End-stage renal disease
    • Dialysis until a renal transplant is available
  • Anemia of chronic kidney disease
    • Administer synthetic EPO, possibly in conjunction with iron replacement depending on serum ferritin and transferrin values.
      • Adverse effects: increased risk of thrombosis, increase in blood pressure
    • RBC transfusion may be needed in cases of EPO resistance
  • Metabolic diseases
    • Hyperlipidemia: statins
    • Diabetes mellitus: Insulin dose may have to be decreased.
    • Restrict protein intake to 0.8–1.0 g/kg/day
  • Actively bleeding or about to undergo a surgical procedure
    • Desmopressin (DDAVP): first-line therapy
    • Cryoprecipitate: life-threatening bleeding resistant to treatment with desmopressin
    • Conjugated estrogens: for chronic control of bleeding
    • Correction of anemia
    • Dialysis

References:^{[13][14][16][17][18][19][20][21][21]}

Classification based on glomerular filtration rate

Classification based on albuminuria

• One-Minute Telegram 14-2020-3/3: GFR formulas are just estimates, but can we estimate better?

Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.

1. Levey AS, Inker LA. Definition and Staging of Chronic Kidney Disease in Adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults.Last updated: November 16, 2016. Accessed: April 17, 2017.
2. Papadakis MA, McPhee SJ, Rabow MW. CURRENT Medical Diagnosis and Treatment 2016. McGraw-Hill Education ; 2015
3. National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States, 2014. https://www.cdc.gov/diabetes/pubs/pdf/kidney_factsheet.pdf. Updated: January 1, 2014. Accessed: April 17, 2017.
4. Goodman CC, Fuller KS. Pathology. Elsevier Health Sciences ; 2014
5. 2015 Kidney Disease Statistics.
6. Longmore M, Wilkinson IB, Davidson EH, Foulkes A, Mafi AR. Oxford Handbook of Clinical Medicine (2010). OUP Oxford ; 2010
7. Mount DB. Treatment and Prevention of Hyperkalemia in Adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/treatment-and-prevention-of-hyperkalemia-in-adults.Last updated: September 29, 2016. Accessed: February 9, 2017.
8. Goldman L, Schafer AI. Goldman-Cecil Medicine, 25th Edition. Elsevier ; 2016
9. Greenberg A, National Kidney Foundation. Primer on Kidney Diseases. Academic Press ; 1994
10. Quarles LD, Berkoben M. Management of Secondary Hyperparathyroidism and Mineral Metabolism Abnormalities in Dialysis Patients. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/management-of-secondary-hyperparathyroidism-and-mineral-metabolism-abnormalities-in-dialysis-patients.Last updated: February 2, 2017. Accessed: April 17, 2017.
11. Black RM. Pericarditis in Renal Failure. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/pericarditis-in-renal-failure.Last updated: June 9, 2015. Accessed: April 17, 2017.
12. Qunibi WY, Henrich WL. Overview of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/overview-of-chronic-kidney-disease-mineral-and-bone-disorder-ckd-mbd.Last updated: January 19, 2017. Accessed: April 18, 2017.
13. Berns JS, Coutre S. Platelet Dysfunction in Uremia. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/platelet-dysfunction-in-uremia.Last updated: June 26, 2015. Accessed: April 18, 2017.
14. Rosenberg M. Overview of the Management of Chronic Kidney Disease in Adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/overview-of-the-management-of-chronic-kidney-disease-in-adults.Last updated: February 24, 2016. Accessed: April 18, 2017.
15. Arora P. Chronic Kidney Disease. Chronic Kidney Disease. New York, NY: WebMD. http://emedicine.medscape.com/article/238798. Updated: July 24, 2016. Accessed: April 18, 2017.
16. Berns JS. Hyporesponse to Erythropoiesis-Stimulating Agents (ESAs) in Chronic Kidney Disease. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/hyporesponse-to-erythropoiesis-stimulating-agents-esas-in-chronic-kidney-disease.Last updated: January 13, 2017. Accessed: January 4, 2018.
17. Decker BS, Molitoris BA. Manifestations of and Risk Factors for Aminoglycoside Nephrotoxicity. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity.Last updated: May 21, 2015. Accessed: April 18, 2017.
18. Portilla D, Safar M, Shannon ML, Penson RT. Cisplatin Nephrotoxicity. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/cisplatin-nephrotoxicity.Last updated: December 15, 2016. Accessed: April 18, 2017.
19. Sterns RH. Amphotericin B Nephrotoxicity. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/amphotericin-b-nephrotoxicity.Last updated: December 3, 2015. Accessed: April 18, 2017.
20. Weaver VM, Jaar BG. Lead nephropathy and lead-related nephrotoxicity. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/lead-nephropathy-and-lead-related-nephrotoxicity.Last updated: March 22, 2017. Accessed: April 18, 2017.
21. Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with chronic kidney disease. Clin Diabetes Endocrinol. 2015; 1 (1). doi: 10.1186/s40842-015-0001-9 . | Open in Read by QxMD
22. Guideline summary: KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. https://www.guideline.gov/summaries/summary/39430?search=chronic%20kidney%20disease. Updated: December 1, 2012. Accessed: April 17, 2017.
23. Chronic Kidney Disease. http://5minuteconsult.com/collectioncontent/1-151514/diseases-and-conditions/chronic-kidney-disease. Updated: July 1, 2016. Accessed: April 18, 2017.
24. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States..